Daoqi Wang

539 total citations
25 papers, 330 citations indexed

About

Daoqi Wang is a scholar working on Reproductive Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daoqi Wang has authored 25 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Reproductive Medicine, 8 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daoqi Wang's work include Sperm and Testicular Function (4 papers), Kidney Stones and Urolithiasis Treatments (3 papers) and Pediatric Urology and Nephrology Studies (3 papers). Daoqi Wang is often cited by papers focused on Sperm and Testicular Function (4 papers), Kidney Stones and Urolithiasis Treatments (3 papers) and Pediatric Urology and Nephrology Studies (3 papers). Daoqi Wang collaborates with scholars based in China, United States and Israel. Daoqi Wang's co-authors include Sanghee Park, Bradley M. Broom, Ganiraju C. Manyam, Guang Yang, Chuandong Geng, Timothy C. Thompson, Paul G. Corn, Shan Peng, Cheng Wu and Zhe Tang and has published in prestigious journals such as Clinical Cancer Research, IEEE Transactions on Geoscience and Remote Sensing and Optics Express.

In The Last Decade

Daoqi Wang

21 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daoqi Wang China 11 130 118 108 79 48 25 330
Kaname Uno Japan 11 96 0.7× 37 0.3× 80 0.7× 88 1.1× 66 1.4× 43 398
Olivier Marpeau France 9 46 0.4× 107 0.9× 109 1.0× 138 1.7× 51 1.1× 16 452
Bangbei Wan China 9 153 1.2× 107 0.9× 49 0.5× 36 0.5× 11 0.2× 33 319
Felicia Roncolato Australia 8 59 0.5× 55 0.5× 133 1.2× 75 0.9× 11 0.2× 31 247
Angela Bowman United Kingdom 12 92 0.7× 67 0.6× 118 1.1× 110 1.4× 18 0.4× 16 407
Lindsay W. Brubaker United States 9 246 1.9× 59 0.5× 196 1.8× 108 1.4× 10 0.2× 28 514
T Goto Japan 9 164 1.3× 29 0.2× 45 0.4× 84 1.1× 34 0.7× 27 366
Erin A. Blake United States 14 53 0.4× 59 0.5× 177 1.6× 227 2.9× 31 0.6× 31 474
Dae Hoon Jeong South Korea 13 95 0.7× 46 0.4× 116 1.1× 194 2.5× 121 2.5× 44 607
M.M. Boisen United States 13 101 0.8× 47 0.4× 70 0.6× 169 2.1× 10 0.2× 45 401

Countries citing papers authored by Daoqi Wang

Since Specialization
Citations

This map shows the geographic impact of Daoqi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daoqi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daoqi Wang more than expected).

Fields of papers citing papers by Daoqi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daoqi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daoqi Wang. The network helps show where Daoqi Wang may publish in the future.

Co-authorship network of co-authors of Daoqi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Daoqi Wang. A scholar is included among the top collaborators of Daoqi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daoqi Wang. Daoqi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Jiahong, Daoqi Wang, Qin Xu, et al.. (2025). CEBPB regulates ERK1/2 activity through SOS1 and contributes to ovarian cancer progression. Medical Oncology. 42(7). 242–242.
2.
4.
Tan, Jiahong, Daoqi Wang, Wei Dong, et al.. (2024). Comprehensive Analysis of CCAAT/Enhancer Binding Protein Family in Ovarian Cancer. Cancer Informatics. 23. 2683902437–2683902437. 1 indexed citations
5.
Wang, Daoqi, Jiahong Tan, Jinming Xu, et al.. (2023). Impact of body mass index on size and composition of urinary stones: a systematic review and meta-analysis. International braz j urol. 49(3). 281–298. 10 indexed citations
6.
Manyam, Ganiraju C., Jody V. Vykoukal, Johannes F. Fahrmann, et al.. (2023). SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression. Clinical Cancer Research. 29(21). 4464–4478. 11 indexed citations
7.
Liu, Jianhe, et al.. (2023). The effect of perioperative pelvic floor muscle exercise on urinary incontinence after radical prostatectomy: a meta-analysis. International braz j urol. 49(4). 441–451. 5 indexed citations
8.
Sun, Taotao, Wenchao Xu, Hao Xu, et al.. (2023). Hormonal therapy is effective and safe for cryptorchidism caused by idiopathic hypogonadotropic hypogonadism in adult males. Frontiers in Endocrinology. 13. 1095950–1095950. 2 indexed citations
9.
He, Weiwei, et al.. (2022). Influence of Scattered Sunlight for Wind Measurements with the O2(a1Δg) Dayglow. Remote Sensing. 15(1). 232–232. 3 indexed citations
11.
Tan, Jiahong, Yuchen Feng, Daoqi Wang, et al.. (2022). Protein expression profiling identifies a prognostic model for ovarian cancer. BMC Women s Health. 22(1). 292–292. 3 indexed citations
12.
Zhou, Yuan, Rui Chen, Daoqi Wang, et al.. (2022). The influencing factors of infectious complications after percutaneous nephrolithotomy: a systematic review and meta-analysis. Urolithiasis. 51(1). 17–17. 28 indexed citations
13.
Wang, Daoqi, Jiajia Xiang, Bin Yang, et al.. (2022). Comparison of postoperative outcomes of mini percutaneous nephrolithotomy and standard percutaneous nephrolithotomy: a meta-analysis. Urolithiasis. 50(5). 523–533. 29 indexed citations
14.
Tang, Zhe, Patrick G. Pilié, Chuandong Geng, et al.. (2021). ATR Inhibition Induces CDK1–SPOP Signaling and Enhances Anti–PD-L1 Cytotoxicity in Prostate Cancer. Clinical Cancer Research. 27(17). 4898–4909. 97 indexed citations
15.
Tan, Jiahong, Chunyan Song, Daoqi Wang, et al.. (2021). Expression of hormone receptors predicts survival and platinum sensitivity of high-grade serous ovarian cancer. Bioscience Reports. 41(5). 10 indexed citations
16.
Chen, Yinwei, Taotao Sun, Daoqi Wang, et al.. (2021). A partial loss-of-function variant in GNRNR gene in a Chinese cohort with idiopathic hypogonadotropic hypogonadism. Translational Andrology and Urology. 10(4). 1676–1687. 2 indexed citations
17.
Feng, Yuchen, et al.. (2021). Predictive value of RAD51 on the survival and drug responsiveness of ovarian cancer. Cancer Cell International. 21(1). 249–249. 24 indexed citations
18.
Wang, Daoqi, Jiahong Tan, Yinwei Chen, et al.. (2020). Combined in vitro and in silico analyses of FGFR1 variants: genotype‐phenotype study in idiopathic hypogonadotropic hypogonadism. Clinical Genetics. 98(4). 341–352. 7 indexed citations
19.
Chen, Yinwei, Taotao Sun, Daoqi Wang, et al.. (2020). Correlations Among Genotype and Outcome in Chinese Male Patients with Congenital Hypogonadotropic Hypogonadism Under HCG Treatment. The Journal of Sexual Medicine. 17(4). 645–657. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026